Kourkoutas D, Buys Y M, Flanagan J G, Karamaounas N, Georgopoulos G, Iliakis E, Moschos M M, Trope G E
Department of Ophthalmology, 401 Hellenic Army General Hospital, 138 Mesogion & Katehaki Avenue, 11525 Athens, Greece.
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, Canada M5T 2S8.
J Ophthalmol. 2014;2014:987389. doi: 10.1155/2014/987389. Epub 2014 Jan 21.
Aim. To investigate the ability of Heidelberg Retina Tomograph (HRT3) Topographic Change Analysis (TCA) map to predict the subsequent development of clinical change, in patients with glaucoma. Materials. 61 eyes of 61 patients, which, from a retrospective review were defined as stable on optic nerve head (ONH) stereophotographs and visual field (VF), were enrolled in a prospective study. Eyes were classified as TCA-stable or TCA-progressed based on the TCA map. All patients underwent HRT3, VF, and ONH stereophotography at 9-12 months intervals. Clinical glaucoma progression was determined by masked assessment of ONH stereophotographs and VF Guided Progression Analysis. Results. The median (IQR) total HRT follow-up period was 8.1 (7.3, 9.1) years, which included a median retrospective and prospective follow-up time of 3.9 (3.1, 5.0) and 4.0 (3.5, 4.7) years, respectively. In the TCA-stable eyes, VF and/or photographic progression occurred in 5/13 (38.4%) eyes compared to 11/48 (22.9%) of the TCA-progressed eyes. There was no statistically significant association between TCA progression and clinically relevant (photographic and/or VF) progression (hazard ratio, 1.18; P = 0.762). The observed median time to clinical progression from enrollment was significantly shorter in the TCA-progressed group compared to the TCA-stable group (P = 0.04). Conclusion. Our results indicate that the commercially available TCA progression criteria do not adequately predict subsequent photographic and/or VF progression.
目的。研究海德堡视网膜断层扫描仪(HRT3)地形变化分析(TCA)图预测青光眼患者临床变化后续发展的能力。材料。对61例患者的61只眼进行了前瞻性研究,这些患者经回顾性分析,其视神经乳头(ONH)立体照片和视野(VF)被判定为稳定。根据TCA图将眼睛分为TCA稳定或TCA进展型。所有患者每隔9 - 12个月接受一次HRT3、VF和ONH立体摄影检查。通过对ONH立体照片和VF引导进展分析的盲法评估来确定临床青光眼进展情况。结果。HRT总的随访期中位数(IQR)为8.1(7.3,9.1)年,其中回顾性和前瞻性随访时间中位数分别为3.9(3.1,5.0)年和4.0(3.5,4.7)年。在TCA稳定的眼中,5/13(38.4%)的眼睛出现了VF和/或照片进展,而TCA进展型眼中这一比例为11/48(22.9%)。TCA进展与临床相关(照片和/或VF)进展之间无统计学显著关联(风险比,1.18;P = 0.762)。与TCA稳定组相比,TCA进展组从入组到临床进展的观察到的中位时间显著更短(P = 0.04)。结论。我们的结果表明,市售的TCA进展标准不能充分预测后续的照片和/或VF进展。